Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT06739967
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of PPA according to the current clinical criteria (Gorno-Tempini et al., 2011)
* Mild PPA defined using the Progressive Aphasia Severity Scale (PASS)
* Age between 40 and 85 years
* Patients with Italian mother tongue
* Patients with the ability to sign the informed consent
* Patients with the ability to comply with the study procedures
* Patients with stable pharmacological treatment for at least 4 weeks.
Exclusion Criteria:
* Mini-Mental State Exam (MMSE) Score \<15
* Presence of other neurological or psychiatric diseases, including cerebrovascular disease
* Severe and uncorrected hearing loss or visual disturbances
* Inability to repeat multi-syllable words (4 syllables)
* Concurrent participation in other pharmacological and non-pharmacological experimental studies
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT06739967
Study Brief:
Protocol Section:
NCT06739967